Pharmaguy™ is a Pharma Marketing 'Constructive' Critic, Blogger & Chief Pundit at Pharmaguy.com
In this 5-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies apply resources and their brains to come up with a solution that helps people take their medication and use these insights to develop the next generation of treatments.
In this 2-minute audio snippet, Edward M. Zabrek, M.D., F.A.C.O.G., Medical Editor, SmartPhone Magazine and iPhone Life Magazine and Renee McLeod, PhD, APRN, BC, CPNP-PC, Clinical Professor, Arizona State University College of Nursing & Healthcare Innovation, Office of Transformational Technologies & Organizations, discuss mobile information technology habits of healthcare professionals and how pharmaceutical marketers can leverage the iPhone/Smartphone channel to educate and market to HCPs about their brands.
In this 2-minute audio snippet, Jeff Tangney, CEO & Founder, Doximity, talks about online physician chat rooms and how 'niche' communities are created around specific content posted to the site.
John (PharmaGuy) Mack was a speaker at the April 22,2017, March for Science in Doylestown, PA. He spoke of the need for more scientists to get involved in local politics and for all citizens to elect pro-science leaders and ensure that they rely on evidence, not beliefs, when making decisions about our health, our environment, and our general well-being.
In this 2.5-minute audio snippet, Patricia Alves and Jaclyn Fonteyne, members of the Boehringer Ingelheim Social Media Team, talk about the working with legal-regulatory to plan TweetChats and what they consider to be the measures of success -- aka, return on investment -- for pharma TweetChats.
Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, describes a urine analysis mobile app that illustrates why the mobile health app industry needs more consistent and balanced FDA enforcement of mobile regulations.
In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).
Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities.